Metraipolis › archive › dc_512de79d290c

The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines — Europe PMC PMID:41683508

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41683508
DOI
10.3390/molecules31030531
License (as archived)
solo-consultazione
Archived
2026-11-06T04:04:56.378Z
SHA-256 of the archived text
5ce872d7b05555bab295f3e9255298200b54745b27ae45b0be397bf357dac3e9
Stable URL of this page
https://metraipolis.com/documento/dc_512de79d290c

How to cite

The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines — Europe PMC PMID:41683508 — Europe PMC (en), https://europepmc.org/article/MED/41683508 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_512de79d290c (Metraipolis archive dc_512de79d290c, sha256 5ce872d7b05555bab295f3e9255298200b54745b27ae45b0be397bf357dac3e9)
BibTeX
@misc{dc512de79d290c,
  title = {The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines — Europe PMC PMID:41683508},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41683508},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_512de79d290c; sha256 5ce872d7b05555bab295f3e9255298200b54745b27ae45b0be397bf357dac3e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41683508. Agents can read the archived copy with the MCP tool read_document.